Skip to content

Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

Prospective Evaluation of Wound Management Using Vacuum Assisted Instillation Therapy in Emergent Contaminated Abdominal Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02127164
Enrollment
18
Registered
2014-04-30
Start date
2014-05-31
Completion date
2017-06-30
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complicated Diverticulitis, Gastrointestinal Injury

Brief summary

Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose using the vacuum assisted device with Dakin's solution on patients undergoing emergency surgery for hollow viscus perforation installed immediately at the end of operation and remained there for the first 3 postoperative days, followed by delayed primary closure on postoperative day 4. The investigators believe this technique can achieve earlier wound closure, decrease patient discomfort, improve cost savings, and potentially standardize and revolutionize the investigators management of heavily contaminated wounds.

Interventions

DEVICEVeraflo device, Dakin's solution

Veraflo device will be installed on the wound to create negative pressure after surgery. Dakin's solution will be instilled through this device into the wound at the regular intervals.

Sponsors

3M
CollaboratorINDUSTRY
University of Arizona
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Emergent surgery involving hollow viscus perforation or necrotic bowel * Admitted to the University of Arizona Medical Center, Tucson, AZ

Exclusion criteria

* Prisoners * Pregnancy * Patients with allergy to Dakin's (sodium hypochlorite) solution.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Surgical Site Infection2 weeksSurgical site infection is defined as the presence of localized inflammatory signs such as hyperthermia, erythema, tenderness, or purulent discharge that results in positive cultures, along with positive wound cultures. Surgical site can also be regarded as infected based on the individual discretion of the treating physician. Surgical sites with \>10\^5 colonization in swab will be considered contaminated.

Secondary

MeasureTime frameDescription
Wong-Baker Faces Pain Rating Scale1 weekThe Wong-Baker Faces Pain Rating scale is used to grade pain related to the presence/manipulation of the device. The Wong-Baker scale range is from 0 (No Hurt) to 10 (Hurts Worst) with numbers increasing by 2 (0, 2, 4, 6, 8, 10) and associated face images showing increased pain and sadness. Higher scores indicate increased pain, a worse outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Veraflo Device, Dakin's Solution
Veraflo device, Dakin's solution: Veraflo device will be installed on the wound to create negative pressure after surgery. Dakin's solution will be instilled through this device into the wound at the regular intervals.
18
Total18

Baseline characteristics

CharacteristicVeraflo Device, Dakin's Solution
Age, Continuous62.7 years
STANDARD_DEVIATION 17.2
BMI28.6 kg/m^2
STANDARD_DEVIATION 5.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
White
14 Participants
Sex: Female, Male
Female
8 Participants
Sex: Female, Male
Male
10 Participants
Smokers7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 18
other
Total, other adverse events
0 / 18
serious
Total, serious adverse events
0 / 18

Outcome results

Primary

Rate of Surgical Site Infection

Surgical site infection is defined as the presence of localized inflammatory signs such as hyperthermia, erythema, tenderness, or purulent discharge that results in positive cultures, along with positive wound cultures. Surgical site can also be regarded as infected based on the individual discretion of the treating physician. Surgical sites with \>10\^5 colonization in swab will be considered contaminated.

Time frame: 2 weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Veraflo Device, Dakin's SolutionRate of Surgical Site Infection5 Participants
Secondary

Wong-Baker Faces Pain Rating Scale

The Wong-Baker Faces Pain Rating scale is used to grade pain related to the presence/manipulation of the device. The Wong-Baker scale range is from 0 (No Hurt) to 10 (Hurts Worst) with numbers increasing by 2 (0, 2, 4, 6, 8, 10) and associated face images showing increased pain and sadness. Higher scores indicate increased pain, a worse outcome.

Time frame: 1 week

ArmMeasureValue (MEAN)
Veraflo Device, Dakin's SolutionWong-Baker Faces Pain Rating Scale6 pain score

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026